TRANSCEND CAPITAL ADVISORS, LLC - APTOSE BIOSCIENCES INC ownership

APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 77 filers reported holding APTOSE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
TRANSCEND CAPITAL ADVISORS, LLC ownership history of APTOSE BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$15,360
+10.3%
24,0000.0%0.00%0.0%
Q4 2022$13,920
-0.6%
24,0000.0%0.00%0.0%
Q3 2022$14,000
-22.2%
24,0000.0%0.00%0.0%
Q2 2022$18,000
-45.5%
24,0000.0%0.00%
-33.3%
Q1 2022$33,000
+3.1%
24,0000.0%0.00%0.0%
Q4 2021$32,000
-36.0%
24,0000.0%0.00%
-25.0%
Q3 2021$50,000
-37.5%
24,0000.0%0.00%
-66.7%
Q2 2021$80,000
-44.4%
24,0000.0%0.01%
-29.4%
Q1 2021$144,00024,0000.02%
Other shareholders
APTOSE BIOSCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Corriente Advisors, LLC 2,900,000$12,702,0003.02%
P.A.W. CAPITAL CORP 750,000$3,285,0002.90%
Prosight Management, LP 824,795$3,613,0001.67%
Voss Capital, LLC 715,000$3,132,0001.58%
DRW Securities, LLC 7,976,176$34,936,0001.23%
Ally Bridge Group (NY) LLC 1,409,150$6,172,0001.06%
Nantahala Capital Management 7,272,673$31,854,0000.99%
SANDERS MORRIS HARRIS LLC 925,153$4,231,0000.96%
PRECEPT MANAGEMENT LLC 440,696$1,930,0000.78%
Endurant Capital Management LP 477,895$2,093,0000.76%
View complete list of APTOSE BIOSCIENCES INC shareholders